Barclays Remains a Hold on Pfizer (PFE)
Goldman Sachs Maintains Pfizer(PFE.US) With Buy Rating, Raises Target Price to $34
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $143
Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Raises Target Price to $35
Jefferies Adjusts Price Target on Pfizer to $35 From $34, Keeps Buy Rating
J.P. Morgan Sticks to Its Hold Rating for Pfizer (PFE)
Evercore Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $192
BNP Paribas Exane Adjusts Price Target on AbbVie to $193 From $172
Evercore ISI Sticks to Its Buy Rating for AbbVie (ABBV)
Johnson & Johnson Analyst Ratings
Evercore Initiates Merck & Co(MRK.US) With Buy Rating
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), AbbVie (ABBV)
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $175
Eli Lilly & Co Faces European Market Challenges; Analyst Maintains Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), AptarGroup (ATR) and AbbVie (ABBV)
Edward Jones Initiates Abbott Laboratories(ABT.US) With Hold Rating
Abbott Laboratories Analyst Ratings
Barclays Maintains Overweight on Abbott Laboratories, Raises Price Target to $143
J.P. Morgan Remains a Buy on UnitedHealth (UNH)